High performance liquid chromatographic assay of indomethacin and its related substances in tablet dosage forms

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL.3, 2012, Pages 549-552

  Tsvetkova, Boyka ^a   Pencheva, Ivanka ^a   Zlatkov, Alexander ^a   Peikov, Plamen ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Impurities; Indomethacin; Liquid chromatography; Stability; Validation

Indexed keywords

4 CHLOROBENZOIC ACID; 5 METHOXY 2 INDOLEACETIC ACID; ACETONITRILE; INDOMETACIN; METHANOL; PHOSPHORIC ACID; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CALIBRATION; DRUG DEGRADATION; DRUG HALF LIFE; DRUG PURITY; DRUG QUALITY; HYDROLYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET; ULTRAVIOLET RADIATION;

EID: 84862621929     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moffat A, Osselton M, Widdop B. Clarke'sAnalysis of Drugs and Poisons. 3rd ed. London, The Pharmaceutical Press, 2004.
2. Roberts Z, Morrow J. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, McGraw-Hill Medical Publishing Division, 2001.
3. European Pharmacopoeia, 5th ed. Council Of Europe, Strasbourg, 2004.
4. Krzek J, Starek M. Simultameous densitometric determination of indomethacin and its degradation products, 4-chlorobenzoic acid and 5-methoxy-2-methyl-3-indoleacetic acid in pharmaceutical preparation. J. AOAC Int. 2001; 84: 1703-1707.
5. Abdel-Hamid M, Novotny L, Hamza H. Determination of diclofenac sodium, flufenamic acid, indomethacin and ketoprofen by LC-APCI-MS. J. Pharm. Biomed. Anal. 2001; 24: 587-594.
6. Plakogiannis F, Ali A, Kazmi S. High performance liquid chromatographic determination of indomethacin in capsules. Drug Dev. Ind. Pharm. 1981; 7: 215-221.
7. Arrunda A, Capiglia A. Phosphorimetric determination of indomethacin in pharmaceutical formulations. Analyst. 1997; 122: 559-562.
8. Arcos J, Lopez-Palacios J, Sanches-Batanero P. Electroanalytical studies of indomethacin. Electroanalysis. 1989; 1: 279-282.
9. Kormosh Z, Hunka I, Bazel Y. Potentiometric sensor for indomethacin determination. Materials Sci. Eng. 2009; C29: 1018-1022.
10. Paula P, Lucia M, Saraiva M, Santos J, Lima J. A pulsed sequential injection analysis flow system for the fluorimetric determination of indomethacin in pharmaceutical preparations. Anal. Chim. Acta. 2005; 539: 173-179.
11. Olajire A, Olaknule S, Ajibola A. Novel colorimetric assay of indomethacin using 4-carboxyl-2,6-dinitrobenzene diazonium ion. Acta Pharm. 2006; 56: 189-202.
12. Baggi T, Mahajan S, Rao G. Colorimetric determination of indomethacin in dosage forms. Ind. J. Pharm. Sci. 1978; 40: 71-72.
13. Sastry C, Mangala D, Rao K. Spectrophotometric and fluorimetric methods for the determination of indomethacin. Analyst. 1986; 111: 323-325.
14. Abdel-Hay M, Korany M, Bedair M, Gazy A. Colorimetric determination of seven non-steroidal anti-inflammatory drugs using 2-nitrophenylhydrazine HCl Anal. Lett. 1990; 23: 281294.
15. Sastry C, Mangala D, Rao K. New sensitive spectrophotometric method for indomethacin. Acta Cienc. India.1986; 126: 17-19.
16. Chowdary K, Rao G, Rao V. Spectrophotometric estimation of indomethacin in dosage forms. Indian Drugs. 1987; 24: 361362.
17. Nagaraja P, Vasantha R, Yathirajan H. Sensitive spectrophotometric method for the determination of indomethacin in capsules. J. Pharm. Biomed. Anal. 2003; 31: 563-569.
18. Novakova L, Matysova L, Havlikova L, Solich P. Development and validation of HPLC method for determination of indomethacin and its two degradation products in topical gel. J. Pharm. Biomed. Anal. 2005; 37: 899-905.
19. Zakova P, Sklenarova H, Novakova L, Hajrova R, Matysova L, Solich P. Application of monolithic columns in pharmaceutical analysis. Determination of indomethacin and its degradation products. J. Sep. Sci. 2009; 32: 2786-2792.
20. Stolarczyk M, Krzek J, Rzeszutko W. Application of derivative spectrophotometry to simultaneous determination of indomethacin and 5-methoxy-2-methyl-3-indoleacetic acid in Metindol injections. J. AOAC Int. 2004; 87: 592-595.
21. Sreekanth N, Rao C. B, Mukkanthi K. RP-HPLC method development and validation of ropinirole hydrochloride in bulk and pharmaceutical dosage forms. Int. J. Pharm. Pharm. Sci. 2009; 1 Suppl. 1: 186-192.
22. Ravichandran K, Shalini S, Sundram K, Harish R. Validation of analytical methods-strategies & importance. Int. J. Pharm. Pharm. Sci. 2010; 2 Suppl. 3: 18-22.
23. Tsvetkova D, Obreshkova D. validation of UV-spectrophotometric method for identification and determination of angiotensin II receptor antagonist losartan potassium. Int. J. Pharm. Pharm. Sci. 2012; 4: 428-431.
24. Mahindra M, Haider S, Ankur K, Amit K. Validation of stability-indicating HPLC method for the determination of enalapril maleate in tablet formulations. Int. J. Pharm. Pharm. Sci. 2011; 3 Suppl. 5: 180-183.
25. Sharath H, Channabasavaraj K, Babu J, Jagadish S. stability-indicating RP-HPLC method for analysis of dorzolamide hydrochloride in the bulk drug and its pharmaceutical dosage forms. Int. J. Pharm. Pharm. Sci. 2011; 3: 100-105.
26. Desai N, Hussen K, Vasanthraju S, Karthik A, Udupa N. Development & validation of stability-indicating HPLC method for determination of solifenacin in bulk formulations. Int. J. Pharm. Pharm. Sci. 2011; 3: 70-74.
27. Sujana K, Sankar D, Souri O, Swathi G. Stability-indicating RP-HPLC method for the determination of telmisartan in pure and pharmaceutical formulations. Int. J. Pharm. Pharm. Sci. 2011; 3 Suppl. 2: 164-167.
28. Gadkari T, Chandrachood P, Shahajietele A, Deshpande N, Salvekar J, Sonawene S. Validated stability indicating LC-PDA-MS method to investigate pH rate profile and degradation kinetics of efavirenz and identification of hydrolysis products by LC-MS. Int. J. Pharm. Pharm. Sci. 2010; 2: 169-176.